RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
1.200
0.00 (0.00%)
Dec 5, 2025, 4:00 PM EST - Market closed
RedHill Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 4 | 8 | 29 | 13 | 135 | 302 | |
| Market Cap Growth | -55.10% | -72.32% | 124.48% | -90.53% | -55.27% | 41.19% | |
| Enterprise Value | 1 | 1 | 24 | 118 | 188 | 353 | |
| Last Close Price | 1.20 | 6.21 | 36.50 | 140.30 | 2580.00 | 8080.00 | |
| PE Ratio | - | - | 1.20 | - | - | - | |
| PS Ratio | 0.19 | 0.99 | 4.40 | 0.21 | 1.58 | 4.70 | |
| PB Ratio | - | -1.70 | 13.88 | -0.26 | 15.23 | 21.80 | |
| EV/Sales Ratio | 0.14 | 0.15 | 3.68 | 1.92 | 2.19 | 5.49 | |
| Debt / Equity Ratio | -0.05 | -0.08 | 0.57 | -2.53 | 9.89 | 6.27 | |
| Asset Turnover | 0.47 | 0.39 | 0.07 | 0.36 | 0.48 | 0.51 | |
| Inventory Turnover | 0.97 | 0.79 | 0.45 | 2.58 | 4.63 | 8.78 | |
| Quick Ratio | 0.37 | 0.34 | 0.44 | 0.28 | 0.87 | 0.81 | |
| Current Ratio | 0.56 | 0.54 | 0.81 | 0.44 | 1.09 | 0.96 | |
| Return on Equity (ROE) | - | - | - | - | -859.70% | -206.25% | |
| Return on Assets (ROA) | -25.32% | -37.28% | -15.71% | -15.75% | -28.06% | -31.30% | |
| Return on Capital (ROIC) | - | - | -36.87% | -31.32% | -51.36% | -48.37% | |
| Return on Capital Employed (ROCE) | 209.20% | 293.20% | -746.30% | 111.00% | -81.40% | -59.50% | |
| Earnings Yield | -233.07% | -103.97% | 83.26% | -560.09% | -72.30% | -25.20% | |
| FCF Yield | -205.49% | -117.93% | -124.74% | -229.63% | -48.20% | -16.21% | |
| Buyback Yield / Dilution | -97.35% | -375.56% | -320.45% | -32.46% | -27.72% | -22.69% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.